RT Journal Article
SR Electronic
T1 Bioimaging Real-Time PXR-Dependent <em>mdr</em>1a Gene Regulation in <em>mdr</em>1a.fLUC Reporter Mice
JF Journal of Pharmacology and Experimental Therapeutics
JO J Pharmacol Exp Ther
FD American Society for Pharmacology and Experimental Therapeutics
SP 438
OP 445
DO 10.1124/jpet.113.203562
VO 345
IS 3
A1 Gu, Long
A1 Chen, Jasmine
A1 Synold, Timothy W.
A1 Forman, Barry M.
A1 Kane, Susan E.
YR 2013
UL http://jpet.aspetjournals.org/content/345/3/438.abstract
AB The MDR1 gene encodes P-glycoprotein, a transmembrane drug efflux transporter that confers multidrug resistance in cancer cells and affects drug pharmacokinetics by virtue of its expression in the liver, kidney, and colon. Nuclear receptors human steroid and xenobiotic receptor (SXR) and constitutive androstane receptor (CAR) are possible master regulators of xenobiotic-inducible MDR1 expression in drug processing organs, but the mechanism of MDR1 regulation has yet to be directly demonstrated in vivo. Moreover, it has previously been impossible to determine the sustained or cumulative effect of repeated doses of xenobiotics on in vivo MDR1 expression. We previously reported a mouse model containing firefly luciferase (fLUC) knocked into the mdr1a genomic locus, allowing noninvasive bioimaging of intestinal mdr1a gene expression in live animals. In the current study, we crossed mdr1a.fLUC mice into the pxr knockout (pxr−/−) genetic background and injected mice with pregnenolone-16α-carbonitrile (PCN), a strong mouse pregnane X receptor (PXR) ligand, and two therapeutically relevant taxanes, paclitaxel and docetaxel. All three agents induced mdr1a.fLUC expression (bioluminescence), but only PCN and docetaxel appeared to act primarily via PXR. Luminescence returned to baseline by 24–48 hours after drug injection and was reinducible over two additional rounds of drug dosing in pxr+/+ mice. TCPOBOP, a CAR ligand, modestly induced mdr1a.fLUC in pxr+/+ and pxr−/− strains, consistent with CAR’s minor role in mdr1a regulation. Collectively, these results demonstrate that the mdr1a.fLUC bioimaging model can capture changes in mdr1 gene expression under conditions of repeated xenobiotic treatment in vivo and that it can be used to probe the mechanism of gene regulation in response to different xenobiotic agents.